Reig Jofre launches sleep supplement in France
Forté Pharma's new nutritional supplement combines natural extracts: valerian, passionflower, and vitamins B3 and B6, which contribute to prolong sleep for 8 hours.
Forté Pharma, Reig Jofre’s nutritional supplements line, has launched Forté Nuit 8h in France, its home market. The new nutritional supplement extends the company's health range and represents the natural alternative to help to fight sleep disorders.
Forté Nuit 8h improves the latency time; it also provides quality rest for 8 hours, without drowsiness or side effects upon awakening and without causing dependence.
Forté Nuit 8h acts with a double effect thanks to its natural formula, the optimal dose of its ingredients and its original bilayer tablets format, which provides an immediate effect through the rapid melatonin release that favors the first phase of the sleep cycle, as well as a long-acting effect thanks to the combination of natural extracts, valerian, passionflower, and vitamins B3 and B6, which contribute to prolong sleep for 8 hours.
Forté Pharma is planning Forté Nuit 8h’s international expansion and will start its marketing in Belgium during the first quarter of 2018.
Regarding the Spanish market, Forté Pharma plans to continue the development of the weight control segment during the first half of the year and to boost the rest of the categories in the second half.
Forte Pharma's portfolio is organized into four segments: energy (35% of its total sales), slimming (30%), health (22%) and beauty (13%) as at the end of September 2017.
At present, the marketing of Forte Pharma products is conducted mostly in Europe through its own sales network. Forte Pharma’s home market - France - is still the first market of the brand, which accounted for 67% of sales.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance